Lars Johansson

Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin

Jan Bolinder, Östen Ljunggren, Joel Kullberg et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 849 citations

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

Automated and reproducible segmentation of visceral and subcutaneous adipose tissue from abdominal MRI

Joel Kullberg, Håkan Åhlström, Lars Johansson et al. · International Journal of Obesity · 2007 · 90 citations

Image Analysis, Subcutaneous Adipose Tissue, Medical Imaging +15

Estimating the prevalence of atrial fibrillation in a general population using validated electronic health data

Lars Johansson, Johannes Norberg, Jan‐Håkan Jansson et al. · Clinical Epidemiology · 2013 · 82 citations · Full text

Age-specific atrial fibrillation incidence, attributable risk factors and risk of stroke and mortality: results from the MORGAM Consortium

Bente Morseth, Bastiaan Geelhoed, Allan Linneberg et al. · Open Heart · 2021 · 62 citations · Full text